Morgan Stanley Lowers Equinor Price Target Following FirstQuarter Results Consumer Sentiment Declines to Record Low in May Amid USIran Tensions and Inflation Fears Starmer Vows Social Media Crackdown Raising Stakes for Tech Regulation AI Wealth Must Benefit the Public South Koreas Deputy PM Says Amid Samsung Labor Tensions Nvidia Stock Declines After Earnings Release Why Some Market Participants May Be Overlooking the LongTerm Picture Safepoint Insurance Targets 116 Billion Valuation in Upcoming US IPO Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline ASAN Q1 2026 Earnings EPS Beats Estimates as Shares Edge Lower AEVA Q1 2026 Earnings Narrower Loss Beats Expectations Shares Slide RILYT Q1 2024 Earnings Net Loss Reported as Holding Company Faces Challenges Notes Rise 11 SOMN Q1 2026 Earnings Earnings Beat Estimates Amid Stable Operations PENG Q1 2026 Earnings EPS Beats Estimates by 2065 Shares Surge PROCEPT BioRobotics PRCT Rises on Positive Momentum Testing Key Resistance at 2847 Once Upon a Farm PBC OFRM Edges Higher as Shares Hold Above Key Support Brag House Holdings Inc TBH Slides 541 Support Levels Under Scrutiny Centurion Acquisition Corp Warrant ALFUW Drops 20 Key Levels in Focus Moodys Corporation MCO Edges Higher Key Support Holds Amid Sector Resilience UK Police Chiefs Propose Blocking Unsafe Social Media for Under16s Posing Regulatory Risk to Platforms MSLE Q1 2026 Earnings EPS Beats Expectations Despite No Revenue Shares Decline Stagwell Inc STGW Surges 537 Can the Rally Continue AMD Surges 778 as Semiconductor Giant Breaks Key Resistance Levels HCM IV Acquisition Corp Unit HACQU Holds Near Trust Value as SPAC Remains in PreBusiness Combination Phase Lincoln National LNC Edges Higher as Shares Test Resistance Near 38 Pediatrix Medical Group MD Holds Steady A Quiet Session Near Key Support Genco Shipping GNK Rides Positive Momentum Gaining 33 Amid Firming Dry Bulk Fundamentals Quest Resource Holding QRHC Slides 26 as Stock Approaches Key Support at 106 Lixte Biotechnology LIXT Slides 525 as Stock Tests Key Support at 532